A case of prolonged peyote-induced psychosis resolved by sleep.
The Journal of Clinical Psychiatry October 1, 2004 DOI: 10.4088/jcp.v65n1020e (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A patient who used peyote and developed psychosis |
| Intervention | Peyote |
| Topics | Mescaline |
| Key findings | A patient's prolonged peyote-induced psychosis resolved after a period of sleep, suggesting that sleep may contribute to recovery from such episodes. |
Abstract
A case of prolonged peyote-induced psychosis resolved by sleep.
Comparable studies
Other case reports and case series on mescaline, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Parkinsonism after Taking Ecstasy 29-year-old man | 1999 | Case study | n = 1 |
| Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology A patient with methylenedioxyamphetamine intoxication | 1981 | Case study | n = 1 |
| A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane | 1955 | Case study | |
| Peyote and mescaline exposures: a 12-year review of a statewide poison center database Patients who used peyote or mescaline and required treatment | 2010 | Case series | |
| A Mescaline Associated Fatality A single deceased individual under the influence of mescaline | 1985 | Case study | n = 1 |
Citations in the library
Cited by 3
- Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports. Psychological Medicine November 20, 2024
- Pharmacologic Similarities and Differences Among Hallucinogens The Journal of Clinical Pharmacology August 1, 2021
- The Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review International Journal of Molecular Sciences March 28, 2026